Erle Refsum

5PUBLICATIONS
14CO-AUTHORS
Foetal development and medicineEpidemiological modellingAutoimmunityHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 09, 2025
Topical retinoid use in women of reproductive age and risk of major congenital malformations in exposed pregnancies: a Nordic cohort study.

Erle Refsum, Kari Furu, Carolyn E Cesta

|Jun 20, 2025
Temporal trends in surgical treatment of inflammatory bowel disease following introduction of biological drugs in Norway and Sweden.

Amanda Högdén, Vera Perrin, Hans-Olov Adami

|May 04, 2023
Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study.

Jingru Yu, Erle Refsum, Paulina Wieszczy

|Feb 02, 2022
Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.

Jingru Yu, Erle Refsum, Lise M Helsingen

|Oct 30, 2021
Long-term colorectal cancer incidence and mortality after adenoma removal in women and men.

Henriette C Jodal, Dagmar Klotz, Magnhild Herfindal

Pageof 1

Frequent Collaborators

2 joint publications

Henriette C Jodal

2 joint publications

Hans-Olov Adami

1 joint publications

Ishita Barua

1 joint publications

Mette Kalager